Brief: Cinclus Pharma Holding Secures EMA And FDA Pediatric Study Waivers For Linaprazan Glurate In H. Pylori Infection
16/06/2025 07:23
June 16 (Reuters) - Cinclus Pharma Holding publ AB CINPHA.ST: SECURES EMA AND FDA PEDIATRIC STUDY WAIVERS FOR LINAPRAZAN GLURATE IN H. PYLORI INFECTION Source text: ID:nMFN2nmdJv Further company coverage: CINPHA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))